• Intranet
DARE-NL
  • About
    • DARE-NL
    • What are ATMPs (ENG)
    • More information
    • Wat zijn ATMPs (NL)
    • Meer weten?
  • Activities
    • Workpackage 1
    • Workpackage 2
    • Workpackage 3
    • Workpackage 4
    • Workpackage 5
    • Workpackage 6
    • Workpackage 7
  • People and Partners
    • Organisation
    • Supporting organisations
    • Management Team
    • Project Team
    • Steering Committee
    • Patient Advisory Board
    • Patient Participation Review Committee
    • Scientific Advisory Board
    • Vacancies
  • Courses & Events
    • Course directory
    • Submit new course
    • External course directories
    • Master courses
    • Upcoming events
    • Past events
    • Annual meeting
      • Annual meeting 2025
      • Annual meeting 2024
        • Program
        • Sponsors
        • Pictures
      • Annual meeting 2023
        • Program
        • Sponsors
        • Pictures
  • Resources
    • Tools
      • ATMP & Regenerative medicine
      • Regulations
      • Costs and lead times
      • Clinical trials
    • Publications
      • All publications
      • News items
      • Scientific articles
    • Newsletters
    • Links
  • Get in touch
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

About Susette Lauwen

This author has not written his bio yet.
But we are proud to say that Susette Lauwen contributed 37 entries already.

Entries by Susette Lauwen

News items

Rapport Academie-gedreven geneesmiddelenontwikkeling door SiRM (in Dutch)

2024-10-17
News items

Behandeling van kanker in een vroeg stadium met innovatieve geneesmiddelen: wat is het ons waard? (in Dutch)

2024-10-08
News items

Pictures annual DARE-NL meeting 2024

2024-10-01
Newsletters

Newsletter September 2024

2024-09-30
Uncategorized

Annual consortium meeting

2024-09-27
News items

Overzicht early access programma’s door Hollandbio (in Dutch)

2024-09-03
News items

Rapport Verkenning aanvaardbaar risico gentherapieonderzoek (in Dutch)

2024-03-14
Newsletters, Uncategorized

Newsletter March 2024

2024-03-13
News items

NTvH artikel ‘DARE-NL: Nederlands platform voor snellere toegang tot ATMP’s bij kanker’ (in Dutch)

2024-03-02
Uncategorized

Program 2024

2024-02-26
Page 2 of 41234

Contact

For questions or comments related to DARE-NL or oncological ATMPs, to become a partner or connect for information

contact us at info@dare-nl.nl.

© DARE-NL

Scroll to top Scroll to top Scroll to top
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}